PRECISION DIAGNOSIS AND MANAGEMENT OF PHEOCHROMOCYTOMA: ADVANCES IN BIOCHEMICAL, IMAGING, AND THERAPEUTIC STRATEGIES

Pheochromocytoma, a rare catecholamine-secreting neuroendocrine tumor arising from adrenal chromaffin cells, presents diagnostic and therapeutic challenges due to its heterogeneous clinical manifestations and potential for life-threatening complications. This comprehensive review synthesizes advancements in diagnostic modalities, including high-sensitivity plasma free metanephrine testing, functional imaging with 68Ga-DOTATATE PET/CT, and genetic profiling for hereditary syndromes such as SDHB-related paragangliomas. Therapeutic strategies, including preoperative alpha-blockade, minimally invasive laparoscopic adrenalectomy, and emerging therapies for metastatic disease, are critically evaluated. Data from 2017–2025 clinical studies demonstrate that integrated diagnostic protocols achieve sensitivities exceeding 95%, while genetic-guided management reduces recurrence rates by 30%. Two novel tables summarize diagnostic test performance and treatment outcomes. Challenges, including misdiagnosis in pregnancy and limited options for malignant pheochromocytoma, are discussed, alongside future directions in precision medicine and radiomics. This review aims to guide clinical practice and inform research priorities.